Full-Time

Leader for GMP Clinical Injectables External and Internal Manufacturing

Posted on 1/10/2025

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior

Framingham, MA, USA

Onsite presence required.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
SAP Products

You match the following Sanofi's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • BS degree in Life Sciences field, or equivalent, plus 5+ yrs. of relevant experience OR MS degree in Life Sciences field with 3 plus years of relevant experience.
Responsibilities
  • In charge for technical agreement (cahier des charges)
  • Ensure the supply of raw materials provided by Sanofi, linking with supply/warehouse functions and track progress of activities
  • Draft and/or contribute to the documentation associated to the transfer activities (Procedures, Formulation Transfer Reports, Technical Conditions, …)
  • Responsible to address clinical manufacturing request (e-BMO)
  • Review and approve the Manufacturing Batch Records (MBR) from the CDMOs
  • Supervise and Person-In-Plant (PiP) at CDMOs facilities, as required
  • Responsible for issuing deviation/events, as required
  • End of production’s declaration in the Enterprise Resource Planning (ERP) like SAP, and ensure the tracking of the shipment of the clinical lot to warehouse or clinical packaging site
  • Responsible for the review of the executed MBR for internal files
  • Ensure the reporting on enforced documents for CIM and GQO
  • Participate to the CDMOs identification and technical assessment in partnership with Sourcing & External Business Development Opportunities Sanofi R&D
  • In charge for manufacturing of clinical lots for Injectables Drug Product forms, with respect of timelines and international Corporate standards for HSE-S and cGMP
  • Supervise the preparation, assess process and project risks and approve the Manufacturing Batch Record
  • Supervise the manufacturing of clinical parenteral drug products with respect of timelines and international Corporate standards for HSE-S and cGMP
  • In charge for HSE risk assessment for operations under her/his responsibility
  • Ensure that the manufacturing requests are addressed within timelines and bring answers, maintain the GMP compliance expectations, report KPIs for her/his activity
  • Ensure the transfer of information between CIM and the Development and/or Pharmaceutical Eng teams done in due time and in partnership. Review and approve the Formulation Transfer Report (FTR). Active member of the transfer meetings
  • Ensure that the manufacturing planning under her/his ownership aligned with RDPM
  • Contribute to the GQO and CIM compliance for her/his activities as part of the CIM Quality plan. Participate to the Quality/HSE audits, as well as follow-up actions. Contribute to the quality management via deviations/events, Change Controls and CAPAs
  • Propose improvements to enable optimal state-of-the-art activities (processes, equipment investment, Quality Assurance, facilities, maintenance, safety…)

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi differentiates itself from competitors by its strong commitment to scientific innovation and a diverse product portfolio that includes prescription medicines and vaccines. Its goal is to enhance health outcomes and improve the quality of life for people globally by delivering effective and safe healthcare solutions.

Company Stage

IPO

Total Funding

$2B

Headquarters

Paris, France

Founded

1973

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA Breakthrough Therapy designation for tolebrutinib boosts Sanofi's neurology leadership.
  • Sanofi's Muse AI tool accelerates patient recruitment, reducing clinical trial timelines.
  • Investment in Zucara Therapeutics strengthens Sanofi's diabetes portfolio with innovative treatments.

What critics are saying

  • Regulatory delays in Japan and China for Sarclisa could impact revenue projections.
  • Liver enzyme elevations in tolebrutinib trials may lead to regulatory scrutiny.
  • Reliance on strategic partnerships poses risks if expected results are not achieved.

What makes Sanofi unique

  • Sanofi's Sarclisa is the first anti-CD38 therapy combined with VRd in the EU.
  • The Care4Rare program focuses on lysosomal storage diseases, offering unique patient solutions.
  • Sanofi's MyWay app enhances patient engagement and medication adherence through digital health.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Professional Development Budget

Parental Leave

INACTIVE